-
Product Insights
NewInterferon Beta – Drugs In Development, 2024
The Interferon Beta pipeline drugs market research report outlays comprehensive information on the Interferon Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Musculoskeletal Disorders, and Respiratory which include indications of Non-Small Cell Lung Cancer, Metastatic Melanoma, Systemic Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus (SCLE), Osteoarthritis, Polymyositis, and Idiopathic Pulmonary Fibrosis. It also reviews key...
-
Product Insights
NewBeta Glucuronidase – Drugs In Development, 2024
The Beta Glucuronidase pipeline drugs market research report outlays comprehensive information on the Beta Glucuronidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Toxicology, Gastrointestinal, and Metabolic Disorders which include indications of Drug Toxicity, Chemotherapy Effects, Gastrointestinal, Inflammatory Bowel Disease, and Mucopolysaccharidosis VII (MPS VII) (Sly Syndrome ). It also reviews key players involved in Beta Glucuronidase...
-
Product Insights
NewBeta Galactosidase – Drugs In Development, 2024
The Beta Galactosidase pipeline drugs market research report outlays comprehensive information on the Beta Galactosidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Gastrointestinal which include indications of GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency), Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ), and Lactose Intolerance (Lactase Deficiency). It also reviews key players involved in Beta...
-
Product Insights
NewBeta Klotho – Drugs In Development, 2024
The Beta Klotho pipeline drugs market research report outlays comprehensive information on the Beta Klotho targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Metabolic Disorders, Musculoskeletal Disorders, and Respiratory which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Type 2 Diabetes, Obesity, Fibrosis, and Idiopathic Pulmonary Fibrosis. It also reviews key...
-
Product Insights
NewIntegrin Beta 7 – Drugs In Development, 2024
The Integrin Beta 7 pipeline drugs market research report outlays comprehensive information on the Integrin Beta 7 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Immunology, and Infectious Disease which include indications of Inflammatory Bowel Disease, Ulcerative Colitis, Immunology, Unspecified Immunological Disorders, and Human Immunodeficiency Virus (HIV) Infections (AIDS). It also reviews key players involved in...
-
Product Insights
NewIntegrin Beta 1 – Drugs In Development, 2024
The Integrin Beta 1 pipeline drugs market research report outlays comprehensive information on the Integrin Beta 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Gastrointestinal, Ophthalmology, and Genetic Disorders which include indications of Solid Tumor, Triple-Negative Breast Cancer (TNBC), Primary Sclerosing Cholangitis, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Wet (Neovascular / Exudative) Macular Degeneration, Keratoconjunctivitis Sicca (Dry...
-
Product Insights
NewEstrogen Receptor Beta – Drugs In Development, 2024
The Estrogen Receptor Beta pipeline drugs market research report outlays comprehensive information on the Estrogen Receptor Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Women's Health, and Musculoskeletal Disorders which include indications of Breast Cancer, Prostate Cancer, Multiple Sclerosis, Alzheimer's Disease, Vasomotor Symptoms of Menopause (Hot Flashes), Post Menopausal Mood Disorder, and...
-
Product Insights
NewIntegrin Beta 6 – Drugs In Development, 2024
The Integrin Beta 6 pipeline drugs market research report outlays comprehensive information on the Integrin Beta 6 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Oncology, Respiratory, and Musculoskeletal Disorders which include indications of Primary Sclerosing Cholangitis, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Oncology, Solid Tumor, Idiopathic Pulmonary Fibrosis, and Fibrosis. It also reviews key players involved in...
-
Product Insights
NewIntegrin Beta 8 – Drugs In Development, 2024
The Integrin Beta 8 pipeline drugs market research report outlays comprehensive information on the Integrin Beta 8 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Musculoskeletal Disorders which include indications of Solid Tumor, Lung Cancer, and Fibrosis. It also reviews key players involved in Integrin Beta 8 targeted therapeutics development with respective active and dormant...
-
Product Insights
NewInterleukin 1 Beta – Drugs In Development, 2024
The Interleukin 1 Beta pipeline drugs market research report outlays comprehensive information on the Interleukin 1 Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Dermatology, Oncology, and Musculoskeletal Disorders which include indications of Inflammation, Rheumatoid Arthritis, Epidermolysis Bullosa, Hidradenitis Suppurativa, Squamous Non-Small Cell Lung Cancer, Metastatic Melanoma, Osteoarthritis, and Gouty Arthritis (Gout). It also reviews...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.